Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02617108
What this trial is testing

Intrauterine Balloon and Postoperative Estrogen Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis

Who this might be right for
Uterine Septum
Fu Xing Hospital, Capital Medical University 310
Testing effectiveness (Phase 2)Study completedNCT03219476
What this trial is testing

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

Who this might be right for
Breast CancerInvasive Breast Cancer
Medical College of Wisconsin 37
Testing effectiveness (Phase 2)Study completedNCT00234676
What this trial is testing

POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease

Who this might be right for
Parkinson's Disease
The Parkinson Study Group 23
Large-scale testing (Phase 3)Study completedNCT00171340
What this trial is testing

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Who this might be right for
Bone LossBreast Cancer
Novartis Pharmaceuticals 1,065
Not applicableUnknownNCT03489473
What this trial is testing

FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment

Who this might be right for
Endometrial Cancer
Radboud University Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT03584009
What this trial is testing

A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy

Who this might be right for
Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche 103
Post-approval studies (Phase 4)UnknownNCT00154180
What this trial is testing

Kronos Early Estrogen Prevention Study (KEEPS)

Who this might be right for
MenopauseArteriosclerosis
Kronos Longevity Research Institute 728
Not applicableStudy completedNCT00883662
What this trial is testing

Mirena Observational Program

Who this might be right for
ContraceptionMenorrhagiaEndometrial Hyperplasia+1 more
Bayer 2,725
Testing effectiveness (Phase 2)UnknownNCT00315107
What this trial is testing

Estrogen Treatment in Acromegalic Women

Who this might be right for
Acromegaly
Université de Montréal 30
Testing effectiveness (Phase 2)Study completedNCT02726971
What this trial is testing

Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion

Who this might be right for
Asherman Syndrome
Fu Xing Hospital, Capital Medical University 141
Not applicableUnknownNCT03329898
What this trial is testing

Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion

Who this might be right for
Intrauterine Adhesion
Beijing Obstetrics and Gynecology Hospital 200
Large-scale testing (Phase 3)Study completedNCT01881230
What this trial is testing

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

Who this might be right for
Breast TumorBreast CancerCancer of the Breast+8 more
Celgene 191
Testing effectiveness (Phase 2)UnknownNCT00077168
What this trial is testing

Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 2,000
Post-approval studies (Phase 4)Study completedNCT00701337
What this trial is testing

Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route

Who this might be right for
Postmenopausal
University Hospital, Toulouse 40
Testing effectiveness (Phase 2)Study completedNCT03321981
What this trial is testing

MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

Who this might be right for
Breast Cancer Metastatic
Merus B.V. 105
Testing effectiveness (Phase 2)Ended earlyNCT01754519
What this trial is testing

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor NegativeEstrogen Receptor Positive+12 more
Roswell Park Cancer Institute 1
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Large-scale testing (Phase 3)Study completedNCT00361569
What this trial is testing

A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy

Who this might be right for
Menopause
Duramed Research 622
Large-scale testing (Phase 3)Active Not RecruitingNCT02947685
What this trial is testing

Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

Who this might be right for
HER-2 Positive Breast CancerEstrogen Receptor Positive Breast Cancer
Alliance Foundation Trials, LLC. 518
Post-approval studies (Phase 4)Study completedNCT00361543
What this trial is testing

Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
The Alfred 54
Next Page